Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Atacicept in a Randomized Trial in Healthy Caucasian and Japanese Subjects

BACKGROUND AND OBJECTIVE: Atacicept is an inhibitor of the B lymphocyte stimulator (BLyS) and a proliferation-inducing ligand (APRIL), and is being studied in relation to immunological disease. Currently, limited data on atacicept are available in non-Caucasian subjects. Pharmacokinetic data from ea...

Descripción completa

Detalles Bibliográficos
Autores principales: Willen, Daniela, Uhl, Wolfgang, Wolna, Peter, Papasouliotis, Orestis, Yalkinoglu, Özkan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6994531/
https://www.ncbi.nlm.nih.gov/pubmed/31529406
http://dx.doi.org/10.1007/s13318-019-00575-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6994531/
https://www.ncbi.nlm.nih.gov/pubmed/31529406
http://dx.doi.org/10.1007/s13318-019-00575-7

Ejemplares similares